Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OTC Switch Interest Cooled By Study Costs To Update Safety Data

Jul 05 2017

• By Eileen Francis

Binocular viewer_1200X675

Related Content

Naloxone Talk Sheds Light On Switch Research Future

Jan 07 2013

Pharma Firm ISO OTC Switch Partner; NDA Experience, Resources Needed

Oct 24 2016

Light Still On For Switches After Pfizer Pulls Plug On OTC <em>Lipitor</em>

Aug 03 2015

Merck Silence On OTC <em>Singulair</em> Speaks Volumes On Switch Outlook

Dec 10 2015

Petition Seeks OTC PPI Warning On Cancer Risk From Persistent Heartburn

May 02 2017

FDA's OTC Naloxone Study Is A Starting Point For Other Switches, Not A Roadmap

May 16 2017

Room For Innovative Switches Could Lurk In Existing FDA Framework

Oct 29 2014

Differin Gel Enters Changed Marketplace Since Last OTC Acne Drug Approval

Aug 22 2016

Related Companies

Merck & Co., Inc.

GSK plc

Sanofi

Additional Topics

United States Prescription To OTC Switch Drug Approval Standards Advertising, Marketing & Sales Manufacturing OTC Drugs Consumer

More from Approval Standards

More from Pathways & Standards

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window